CERO THERAPEUTICS HOLDINGS, INC. (CERO)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Income | — | — | -$7.68M | -$2.91M | — |
| Net Income | -$19.92M | — | -$7.29M | -$667.7K | — |
| EPS (Diluted) | — | — | $-1248.64 | — | — |
| Total Assets | $3.64M | $6.21M | $5.13M | $42.37M | $180.08M |
| Total Liabilities | $9.09M | $8.10M | $5.08M | $39.90M | $9.25M |
| Shareholders' Equity | -$5.45M | -$1.89M | -$42.06M | -$11.00M | -$7.67M |
| Cash & Equivalents | — | — | $96.9K | $475.9K | $1.10M |
| Operating Cash Flow | -$16.10M | — | -$1.52M | -$1.09M | — |
| Shares Outstanding | — | — | 5.8K | — | — |
| Dividends Per Share | $10.37 | — | — | — | — |